Related Articles
Expression patterns of programmed death‑1 and programmed death‑1 ligand‑1 on T cells in gastric cancer
Increased soluble and membrane-bound PD-L1 contributes to immune regulation and disease progression in patients with tuberculous pleural effusion
Antitumor effects of the silencing of programmed cell death ligand 1 in colorectal cancer via immunoregulation
Increased expression of PD‑L1 by the human papillomavirus 16 E7 oncoprotein inhibits anticancer immunity
PD‑L1 expression levels on tumor cells affect their immunosuppressive activity